Flo K, Hansen M, Orbo A, Kjorstad K E, Maltau J M, Sager G
Department of Gynaecology and Obstetrics, University Hospital of Tromso, Norway.
Scand J Clin Lab Invest. 1995 Dec;55(8):715-21. doi: 10.3109/00365519509075401.
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed knowledge about the cellular biokinetics of cGMP (synthesis, metabolic conversion and export). In the present study the transport of cGMP in human erythrocytes has been further characterized. The uptake of cGMP was dependent on a concentration gradient and was temperature-sensitive, compatible with passive diffusion. The cGMP export was temperature-sensitive, saturable (Km = 3.4 +/- 1.0 mu mol l-1), inhibited by probenecid and verapamil and stimulated by progesterone. The results show that human erythrocytes possess a cGMP transport system similar to that found in other cells and that extracellular levels of cGMP are dependent on intracellular levels, membrane transport and influenced by physiological factors and pharmacological agents.
在各种临床病症中均观察到细胞外cGMP水平升高,并且该分析物已被提议作为心血管疾病以及恶性疾病的诊断标志物。然而,将细胞外cGMP用作病理生理标志物需要对cGMP的细胞生物动力学(合成、代谢转化和输出)有详细的了解。在本研究中,已进一步表征了cGMP在人红细胞中的转运。cGMP的摄取依赖于浓度梯度且对温度敏感,这与被动扩散一致。cGMP的输出对温度敏感、具有饱和性(Km = 3.4 +/- 1.0 μmol l-1),可被丙磺舒和维拉帕米抑制,并被孕酮刺激。结果表明,人红细胞拥有一个与其他细胞中发现的类似的cGMP转运系统,并且细胞外cGMP水平取决于细胞内水平、膜转运,并受生理因素和药物制剂的影响。